Search Results for: name
GNPTG Gene Mucolipidosis Type 3 Gamma Genetic Test Cost
The GNPTG gene mucolipidosis type 3 gamma genetic test is a specialized diagnostic procedure aimed at identifying mutations in the GNPTG gene, which are linked to mucolipidosis type III gamma (MLIII gamma), a rare lysosomal storage disorder. This condition affects various bodily systems, leading to symptoms like skeletal abnormalities, joint stiffness, and developmental delays. Early detection through this genetic test can facilitate appropriate management and intervention strategies to improve the quality of life for affected individuals. Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, this test offers a reliable means for diagnosing MLIII gamma. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of mucolipidosis type III gamma, paving the way for tailored treatment approaches and genetic counseling.
MCOLN1 Gene Mucolipidosis Type 4 Genetic Test Cost
The MCOLN1 Gene Mucolipidosis Type 4 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the MCOLN1 gene, which are associated with Mucolipidosis Type IV. This rare genetic disorder affects the body's ability to break down and recycle certain materials, leading to severe developmental delays, vision problems, and motor skill impairments. The test, which costs 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the MCOLN1 gene, providing crucial information for accurate diagnosis and management of the condition. By pinpointing the exact nature of the genetic mutation, healthcare providers can offer targeted treatment plans and support to patients and their families, enhancing the quality of life for those affected by Mucolipidosis Type IV.
IDUA Gene Mucopolysaccharidosis Type 1H Genetic Test Cost
The IDUA Gene Mucopolysaccharidosis Type 1H Genetic Test is a specialized diagnostic procedure designed to detect mutations in the IDUA gene, which are responsible for causing Mucopolysaccharidosis Type 1H (MPS 1H), also known as Hurler syndrome. This condition is a rare, inherited lysosomal storage disorder characterized by the body's inability to break down certain long chains of sugar molecules called glycosaminoglycans. The accumulation of these molecules in various body tissues leads to a range of symptoms including developmental delay, skeletal and joint abnormalities, and organ dysfunction. The test involves analyzing the patient's DNA, extracted from a blood sample, to identify any mutations in the IDUA gene that are indicative of MPS 1H. It is a crucial tool for early diagnosis, which can significantly impact the management and treatment of the disease, potentially improving the quality of life and lifespan of affected individuals. The IDUA Gene Mucopolysaccharidosis Type 1H Genetic Test is available at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed. Early diagnosis through this test can facilitate timely intervention and access to supportive therapies, making it a valuable resource for families with a history of MPS 1H.
IDS Gene Mucopolysaccharidosis Type 2 Genetic Test Cost
The IDS Gene Mucopolysaccharidosis Type 2 (MPS II), also known as Hunter syndrome, is a rare genetic disorder caused by a deficiency in the enzyme iduronate-2-sulfatase. This enzyme is crucial for breaking down certain complex molecules, and its deficiency leads to the accumulation of these molecules in body tissues, leading to various symptoms including skeletal abnormalities, cognitive impairment, and heart disease. The condition is inherited in an X-linked recessive pattern, affecting mainly males. To diagnose this condition, a genetic test targeting the IDS gene can be conducted. This test involves analyzing the DNA to identify mutations in the IDS gene that are responsible for MPS II. Early diagnosis through genetic testing is vital for the management and treatment of the disorder, allowing for interventions that can improve quality of life and prolong lifespan. In the United Arab Emirates, DNA Labs UAE offers this specific genetic test for the IDS gene. The cost of the test is 4400 AED. DNA Labs UAE is equipped with advanced genetic testing technologies to ensure accurate and reliable results. This test is recommended for individuals with a family history of Hunter syndrome or those exhibiting symptoms associated with the disorder. It is also a crucial step for families considering genetic counseling.
SGSH Gene Mucopolysaccharidosis Type 3A Genetic Test Cost
The SGSH Gene Mucopolysaccharidosis Type 3A Genetic Test is a specialized diagnostic tool designed to identify mutations in the SGSH gene, which are responsible for Mucopolysaccharidosis Type 3A (MPS IIIA), also known as Sanfilippo syndrome type A. This condition is a rare, inherited metabolic disorder characterized by the body's inability to properly break down certain sugar molecules, leading to severe neurological symptoms and physical impairments. The test is crucial for early diagnosis, which can aid in managing symptoms and improving the quality of life for affected individuals. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the SGSH gene to detect the presence of mutations. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variants associated with MPS IIIA. This test is particularly important for families with a history of the condition or for individuals showing symptoms related to MPS IIIA, providing them with essential information for genetic counseling and potential treatment strategies.
NAGLU Gene Mucopolysaccharidosis Type 3B Genetic Test Cost
The NAGLU Gene Mucopolysaccharidosis Type 3B Genetic Test is a specialized diagnostic procedure designed to identify mutations in the NAGLU gene, which are responsible for causing Mucopolysaccharidosis Type 3B (MPS IIIB), also known as Sanfilippo Syndrome Type B. This condition is a rare genetic disorder that affects the body's ability to break down large sugar molecules called glycosaminoglycans, leading to their accumulation in cells and tissues, which can cause severe neurological symptoms and physical impairments. The test is conducted through DNA analysis, where a sample of the patient's blood or saliva is collected and examined for specific genetic alterations in the NAGLU gene. Identifying these mutations can confirm a diagnosis of MPS IIIB, which is crucial for early intervention, management strategies, and genetic counseling for affected families. Performed at DNA Labs UAE, a leading facility in genetic testing, the cost of the NAGLU Gene Mucopolysaccharidosis Type 3B Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to detect the genetic variations associated with this condition, providing essential information for healthcare providers, patients, and their families to navigate the challenges of MPS IIIB.
HGSNAT Gene Mucopolysaccharidosis Type 3C Genetic Test Cost
The HGSNAT gene plays a critical role in the body's ability to break down certain large sugar molecules. Mutations in this gene can lead to a rare and severe disorder known as Mucopolysaccharidosis Type 3C (MPS IIIC), also referred to as Sanfilippo Syndrome Type C. This condition is characterized by the body's inability to properly degrade heparan sulfate, leading to its accumulation and causing progressive damage to the nervous system. Symptoms often include developmental delay, behavioral problems, and progressive intellectual decline. To diagnose this condition, genetic testing for mutations in the HGSNAT gene is essential. DNA Labs UAE offers a comprehensive genetic test specifically designed to detect mutations in the HGSNAT gene that are associated with Mucopolysaccharidosis Type 3C. The test is crucial for early diagnosis, which can help in managing the symptoms and planning for the care of individuals affected by MPS IIIC. The cost of the HGSNAT gene Mucopolysaccharidosis Type 3C genetic test at DNA Labs UAE is 4400 AED. This investment covers the process of collecting a DNA sample, usually through a blood draw or cheek swab, and the detailed analysis conducted in their state-of-the-art laboratory facilities. Early detection through this genetic test can be a vital step in providing the necessary interventions and support for those affected by this challenging condition.
GNS Gene Mucopolysaccharidosis Type 3D Genetic Test Cost
The GNS Gene Mucopolysaccharidosis Type 3D Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the GNS gene that are responsible for Mucopolysaccharidosis Type 3D (MPS IIID). MPS IIID is a rare genetic disorder characterized by the body's inability to break down certain large molecules, leading to severe symptoms that can affect the brain and other parts of the body. This condition is part of a group of diseases known as lysosomal storage disorders. The test involves analyzing the patient's DNA to detect mutations in the GNS gene, which provides instructions for producing an enzyme necessary for the breakdown of glycosaminoglycans (GAGs). In MPS IIID, mutations in the GNS gene lead to deficient activity of this enzyme, causing an accumulation of GAGs in cells throughout the body. This accumulation can result in symptoms such as developmental delay, behavioral problems, and physical disabilities. At DNA Labs UAE, the GNS Gene Mucopolysaccharidosis Type 3D Genetic Test is priced at 4400 AED. The test is crucial for early diagnosis and management of the condition, allowing for appropriate therapeutic interventions and genetic counseling for affected families. The results from this test can provide valuable information for planning treatment strategies and improving the quality of life for individuals with MPS IIID.